Kyowa Kirin

About

Kyowa Kirin, engages in the manufacture and sale of medical products and pharmaceuticals in the therapeutic areas of nephrology, oncology, and immunology in Japan. Its pharmaceutical products include GRAN, a protein that enables a quick recovery from neutropenia and reduces the risk of infection; NESP, an agent for correcting anemia; ESPO, a glycoprotein, which acts as an anemia-relieving treatment for dialysis patients; and CONIEL, a calcium antagonist agent for hypertension and angina pectoris. The company's pharmaceutical products also comprise REGPARA an agent for the treatment of secondary hyperparathyroidism; ALLELOCK/Patanol, which are used as medicine for patients with various types of allergies; and DEPAKENE/TOPINA, antiepileptic agents. It also offers a range of products, including amino acids, nucleic acids, vitamins, and sugars, which are used to produce pharmaceuticals, health foods, foods, cosmetics, and other products; plant growth regulators, feed additives, companion a

Investment Focus

Stages

growth late-stage

Sectors

healthtech biotech

Location

Tokyo, Japan